1163258006: Saroglitazar (substance)

SNOMED CT Concept\Substance\...

\Substance categorized by disposition\Receptor agonist\Peroxisome proliferator-activated receptor agonist\Saroglitazar

\A grouper concept for substances that are used in medicinal products for medical treatment, and also psychoactive substances that have few or no legitimate medical uses or that are not legally available to the person using them.\Peroxisome proliferator-activated receptor agonist\Saroglitazar

\Substance categorised by structure\Chemical\Chemical categorized by structure (substance)\...

\Nitrogen and/or nitrogen compound (substance)\Nitrogen compound\Organic nitrogen compound\Azole\Pyrrole\Saroglitazar

\Organic compound\Organic cyclic compound\Heterocyclic compound\Azole\Pyrrole\Saroglitazar
\Organic compound\Organic nitrogen compound\Azole\Pyrrole\Saroglitazar

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 30-Sep 2021. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module

4594928012 Saroglitazar en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

4594929016 Saroglitazar (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core

Expanded Value Set

Outbound Relationships	Type	Target	Active	Characteristic	Refinability	Group	Values
Saroglitazar	Is a	Pyrrole	true	Inferred relationship	Some
Saroglitazar	Is a	Peroxisome proliferator-activated receptor agonist	true	Inferred relationship	Some
Saroglitazar	This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context.	Peroxisome proliferator-activated receptor agonist	true	Inferred relationship	Some

Inbound Relationships	Type	Active	Source	Characteristic	Refinability	Group
Saroglitazar 4 mg oral tablet	The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration).	True	Saroglitazar	Inferred relationship	Some	1
Saroglitazar 4 mg oral tablet	This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon.	True	Saroglitazar	Inferred relationship	Some	1
Saroglitazar only product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saroglitazar	Inferred relationship	Some	1
Saroglitazar-containing product in oral dose form	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saroglitazar	Inferred relationship	Some	1
Product containing only saroglitazar (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saroglitazar	Inferred relationship	Some	1
Product containing saroglitazar (medicinal product)	The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications.	True	Saroglitazar	Inferred relationship	Some	1

This concept is not in any reference sets